{"title":"AI-Driven Wearable Bioelectronics in Digital Healthcare.","authors":"Guangqi Huang, Xiaofeng Chen, Caizhi Liao","doi":"10.3390/bios15070410","DOIUrl":null,"url":null,"abstract":"<p><p>The integration of artificial intelligence (AI) with wearable bioelectronics is revolutionizing digital healthcare by enabling proactive, personalized, and data-driven medical solutions. These advanced devices, equipped with multimodal sensors and AI-powered analytics, facilitate real-time monitoring of physiological and biochemical parameters-such as cardiac activity, glucose levels, and biomarkers-allowing for early disease detection, chronic condition management, and precision therapeutics. By shifting healthcare from reactive to preventive paradigms, AI-driven wearables address critical challenges, including rising chronic disease burdens, aging populations, and healthcare accessibility gaps. However, their widespread adoption faces technical, ethical, and regulatory hurdles, such as data interoperability, privacy concerns, algorithmic bias, and the need for robust clinical validation. This review comprehensively examines the current state of AI-enhanced wearable bioelectronics, covering (1) foundational technologies in sensor design, AI algorithms, and energy-efficient hardware; (2) applications in continuous health monitoring, diagnostics, and personalized interventions; (3) key challenges in scalability, security, and regulatory compliance; and (4) future directions involving 5G, the IoT, and global standardization efforts. We highlight how these technologies could democratize healthcare through remote patient monitoring and resource optimization while emphasizing the imperative of interdisciplinary collaboration to ensure equitable, secure, and clinically impactful deployment. By synthesizing advancements and critical gaps, this review aims to guide researchers, clinicians, and policymakers toward responsible innovation in the next generation of digital healthcare.</p>","PeriodicalId":48608,"journal":{"name":"Biosensors-Basel","volume":"15 7","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12294109/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosensors-Basel","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bios15070410","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The integration of artificial intelligence (AI) with wearable bioelectronics is revolutionizing digital healthcare by enabling proactive, personalized, and data-driven medical solutions. These advanced devices, equipped with multimodal sensors and AI-powered analytics, facilitate real-time monitoring of physiological and biochemical parameters-such as cardiac activity, glucose levels, and biomarkers-allowing for early disease detection, chronic condition management, and precision therapeutics. By shifting healthcare from reactive to preventive paradigms, AI-driven wearables address critical challenges, including rising chronic disease burdens, aging populations, and healthcare accessibility gaps. However, their widespread adoption faces technical, ethical, and regulatory hurdles, such as data interoperability, privacy concerns, algorithmic bias, and the need for robust clinical validation. This review comprehensively examines the current state of AI-enhanced wearable bioelectronics, covering (1) foundational technologies in sensor design, AI algorithms, and energy-efficient hardware; (2) applications in continuous health monitoring, diagnostics, and personalized interventions; (3) key challenges in scalability, security, and regulatory compliance; and (4) future directions involving 5G, the IoT, and global standardization efforts. We highlight how these technologies could democratize healthcare through remote patient monitoring and resource optimization while emphasizing the imperative of interdisciplinary collaboration to ensure equitable, secure, and clinically impactful deployment. By synthesizing advancements and critical gaps, this review aims to guide researchers, clinicians, and policymakers toward responsible innovation in the next generation of digital healthcare.
Biosensors-BaselBiochemistry, Genetics and Molecular Biology-Clinical Biochemistry
CiteScore
6.60
自引率
14.80%
发文量
983
审稿时长
11 weeks
期刊介绍:
Biosensors (ISSN 2079-6374) provides an advanced forum for studies related to the science and technology of biosensors and biosensing. It publishes original research papers, comprehensive reviews and communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. Electronic files and software regarding the full details of the calculation or experimental procedure, if unable to be published in a normal way, can be deposited as supplementary electronic material.